 |
Finch Therapeutics
Last updated: April 15, 2024
CEO Mark Smith
Country: USA | Funding: $188.8M (+)
Website: http://finchtherapeutics.com/
Finch Therapeutics Group is a clinical-stage biopharmaceutical company focused on developing and delivering innovative therapies that harness the human gut microbiome.
Website: http://finchtherapeutics.com/
Finch Therapeutics Group is a clinical-stage biopharmaceutical company focused on developing and delivering innovative therapies that harness the human gut microbiome.
